https://orcid.org/0000-0001-8328-4608
References
- Takenoshita M, Sato T, Kato Y, et al. Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities. Neuropsychiatr Dis Treat. 2010;6:699–705. doi:10.2147/NDT.S12605
- Maier C. Vital disorders of the mouth (glossodynia) in depressive involutional psychoses. Nervenarzt. 1986;57(2):113–115.
- Eli I, Baht R, Littner MM, Kleinhauz M. Detection of psychopathologic trends in glossodynia patients. Psychosom Med. 1994;56(5):389–394. doi:10.1097/00006842-199409000-00002
- Inamitsu T. Functional somatic syndrome in dental practice. Nihon Rinsho. 2009;67(9):1749–1754.
- Davies SJ, Underhill HC, Abdel-Karim A, et al. Individual oral symptoms in burning mouth syndrome may be associated differentially with depression and anxiety. Acta Odontol Scand. 2016;74(2):155–160. doi:10.3109/00016357.2015.1100324
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington DC: American Psychiatric Association; 2013.
- Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278–296. doi:10.1111/j.2044-8260.1967.tb00530.x
- Girardi P, Pompili M, Innamorati M, et al. Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods. Hum Psychopharmacol. 2009;24(3):177–190. doi:10.1002/hup.1005
- Zakrzewska J, Buchanan JA. Burning mouth syndrome. BMJ Clin Evid. 2016;2016:1301.
- Ueda N, Kodama Y, Hori H, et al. Two cases of burning mouth syndrome treated with olanzapine. Psychiatry Clin Neurosci. 2008;62(3):359–361. doi:10.1111/j.1440-1819.2008.01806.x
- Baldo P, Doree C, Molin P, McFerran D, Cecco S, Antidepressants for patients with tinnitus. Cochrane Database Syst Rev. 2012;9:CD003853. doi:10.1002/14651858.CD003853.pub3
- Adamo D, Pecoraro G, Aria M, Favia G, Mignogna MD. Vortioxetine in the treatment of mood disorders associated with burning mouth syndrome: results of an open-label, flexible-dose pilot study. Pain Med. 2020;21(1):185–194. doi:10.1093/pm/pnz120
- Teruel A, Patel S. Burning mouth syndrome: a review of etiology, diagnosis, and management. Gen Dent. 2019;67(2):24–29.
- Gurvits GE, Tan A. Burning mouth syndrome. World J Gastroenterol. 2013;19(5):665–672. doi:10.3748/wjg.v19.i5.665
- Sowa-Kućma M, Pańczyszyn-Trzewik P, Misztak P, et al. Vortioxetine: a review of the pharmacology and clinical profile of the novel antidepressant. Pharmacol Rep. 2017;69:595–601. doi:10.1016/j.pharep.2017.01.030
- Alvarez E, Perez V, Artigas F. Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder. Neuropsychiatr Dis Treat. 2014;10:1297–1307. doi:10.2147/NDT.S41387